Detalhe da pesquisa
1.
Breaking the Silence: An Epidemiological Report on Asian American and Pacific Islander Youth Mental Health and Suicide (1999-2021).
Child Adolesc Ment Health
; 29(2): 136-144, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38525866
2.
Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis.
J Pediatr Gastroenterol Nutr
; 75(2): 186-191, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35666852
3.
No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects.
BMC Infect Dis
; 16: 347, 2016 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27450277
4.
Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation.
Eur J Clin Pharmacol
; 72(6): 665-70, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26898568
5.
Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients.
Br J Clin Pharmacol
; 80(3): 502-14, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25819132
6.
Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol.
Ann Pharmacother
; 49(7): 784-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25862012
7.
Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study.
J Infect Dis
; 210(3): 354-62, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24446523
8.
ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects.
Clin Infect Dis
; 59(7): 1032-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24944232
9.
Effect of fosamprenavir-ritonavir on the pharmacokinetics of dolutegravir in healthy subjects.
Antimicrob Agents Chemother
; 58(11): 6696-700, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25155604
10.
Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir.
Eur J Clin Pharmacol
; 70(10): 1173-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25146692
11.
Maribavir: Mechanism of action, clinical, and translational science.
Clin Transl Sci
; 17(1): e13696, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071422
12.
Effect of Food, Crushing of Tablets, and Antacid Coadministration on Maribavir Pharmacokinetics in Healthy Adult Participants: Results From 2 Phase 1, Open-Label, Randomized, Crossover Studies.
Clin Pharmacol Drug Dev
; 13(6): 644-654, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38708555
13.
Effect of prednisone on the pharmacokinetics of the integrase inhibitor dolutegravir.
Antimicrob Agents Chemother
; 57(9): 4394-7, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23817375
14.
Metabolism, excretion, and mass balance of the HIV-1 integrase inhibitor dolutegravir in humans.
Antimicrob Agents Chemother
; 57(8): 3536-46, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23669385
15.
A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects.
Br J Clin Pharmacol
; 75(4): 990-6, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22905856
16.
Maribavir Pharmacokinetics and Safety in Participants With Moderate Hepatic Impairment: A Phase 1, Open-Label, Single-Dose, Parallel Group Study.
J Clin Pharmacol
; 63(2): 250-258, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089648
17.
Pharmacokinetics and Safety Evaluation of Maribavir in Healthy Japanese and Matched White Participants: A Phase 1, Open-Label Study.
Clin Pharmacol Drug Dev
; 12(6): 645-654, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036111
18.
Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus.
CPT Pharmacometrics Syst Pharmacol
; 12(5): 719-723, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36789522
19.
Physiologically Based Pharmacokinetic Modeling for Maribavir to Inform Dosing in Drug-Drug Interaction Scenarios with CYP3A4 Inducers and Inhibitors.
J Clin Pharmacol
; 2023 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38009271
20.
A Phase I Randomized Trial of Once-Daily Versus Twice-Daily Recombinant Human Parathyroid Hormone (1-84) for Hypoparathyroidism.
JBMR Plus
; 7(7): e10758, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37457880